<?xml version="1.0" encoding="UTF-8"?>
<ref id="B80">
 <label>80</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shamsi</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Mohammad</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Anwar</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>AlAjmi</surname>
    <given-names>MF</given-names>
   </name>
   <name>
    <surname>Hussain</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Rehman</surname>
    <given-names>MT</given-names>
   </name>
  </person-group>
  <article-title>Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease possible implication in COVID-19 therapy</article-title>
  <source>Biosci Rep</source>
  <year>2020</year>
  <volume>40</volume>
  <issue>6</issue>
  <fpage>1</fpage>
  <lpage>8</lpage>
 </element-citation>
</ref>
